Health systems across many low- and middle-income countries are straining under the weight of persistent challenges, including critical workforce shortages, fragmented service delivery, and inadequate data systems that limit access to care and perpetuate inequities in health outcomes. These issues
The U.S. Food and Drug Administration has dramatically reshaped the future of personal health technology by rolling out significant updates to its regulatory framework for consumer wearables and artificial intelligence-powered software. Announced by FDA Commissioner Marty Makary, M.D., during the
The dawn of a new year has brought with it a significant realignment of leadership across the American healthcare sector, as a cascade of executive appointments and retirements redefines the strategic direction of major health systems, technology innovators, and influential advocacy organizations.
Navigating the fragmented landscape of personal health information, from disparate lab results and doctor's notes to daily fitness tracker data, has long been a significant challenge for individuals seeking a comprehensive understanding of their own well-being. In response to this growing need for
The biopharmaceutical sector is holding its collective breath as a series of high-stakes regulatory decisions promises to redraw competitive maps and dictate market leadership for years to come. The first quarter is not just another period of clinical trial readouts and earnings reports; it
The journey of a biological specimen from a patient in an operating room to a pathologist's microscope is one of the most critical and high-stakes processes in modern medicine, yet it has remained alarmingly vulnerable to human error. A recent in-depth analysis of a pilot quasi-experimental study
